ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

BTX Brooklyn ImmunoTherapeutics Inc

9.79
0.00 (0.00%)
17 May 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 00000051k17k
Operating Income -6.91M-7.89M-14.29M1.25M-5.32M-4.6M-5.51M-5.77M
Pre Tax Income -9.38M-3.4M-7.31M-4.45M-5.41M-4.5M-5.6M-6.16M
Net Income -9.38M-3.41M-7.32M-4.5M-5.42M-4.52M-5.59M-6.16M
Preferred Dividends 0-8k0-8k0-8k0-8k
Basic Earnings Per Share (EPS) 00000000
EBIT -8.05M-7.89M-14.29M1.33M-5.37M-4.83M-5.51M-5.82M
EBITDA -6.88M-7.82M-14.25M1.27M-5.3M-4.58M-5.49M-5.74M
Year End 31 December 2023 20162017201820192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 22.31M21.27M23.34M19.81M5.8M0068k
Operating Income -2.28M-1.4M203k-1.76M-6.31M-113.73M-27.23M-21.14M
Pre Tax Income -2.89M-1.01M-323k-2.02M-4.42M-122.3M-24.53M-21.67M
Net Income -2.92M-1.08M-275k-2.06M-4.43M-122.32M-24.6M-21.68M
Preferred Dividends 00-16k-16k-16k-16k-16k-16k
Basic Earnings Per Share (EPS) -1.214-0.402-0.091-0.677-1.419-2.344-4.655-3.896
EBIT -2.31M-513k66k-1.77M-4.28M-122.3M-28.4M-21.47M
EBITDA 609k915k3.25M1.67M-3.46M-113.73M-27.07M-21.05M